Morning Briefing
Summaries of health policy coverage from major news organizations
In Midst Of Furor Over High Drug Prices, Pharma Industry Aims To Flip Script With New Ads
Many of the ads, aimed at lawmakers and other influencers, feature patients who have been helped by new medicines, and company scientists working on drug development.
The Wall Street Journal: Drug Industry Launches Ad Campaign Aimed At Lawmakers
The pharmaceutical industry, under fire this election season for rising drug prices, is ramping up a new advertising campaign designed to improve its reputation with lawmakers as it lobbies against any effort to rein in prescription costs. The sector’s largest trade group, the Pharmaceutical Research and Manufacturers of America, or PhRMA, says it intends to spend several million dollars this year, and 10% more than in 2015, on digital, radio and print ads that emphasize the industry’s role in developing new drugs and advancing medical science. (Walker, 2/7)
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
